Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
12.39
-0.13 (-1.04%)
Jan 17, 2025, 4:00 PM EST - Market closed
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2023. The number of employees increased by 100 or 3.85% compared to the previous year.
Employees
2,700
Change (1Y)
100
Growth (1Y)
3.85%
Revenue / Employee
$305,037
Profits / Employee
-$42,963
Market Cap
1.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MYGN News
- 5 days ago - Diligent Announces Market Insights Reporting Powered by S&P Global Market Intelligence, Giving Directors and Executives Unrivaled Financial and Risk Insights - Business Wire
- 11 days ago - Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History - GlobeNewsWire
- 12 days ago - UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 12 days ago - Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 14 days ago - Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report - GlobeNewsWire
- 4 weeks ago - Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics - GlobeNewsWire
- 5 weeks ago - Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing - GlobeNewsWire
- 5 weeks ago - Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member - GlobeNewsWire